Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Tom Miller, PhD, Iambic Therapeutics co-founder and CEO
Iambic Therapeutics has advanced its first pipeline candidate into the clinic, an AI-designed treatment for human epidermal growth factor receptor 2 (HER2)-driven cancers that moved from discovery...
AACR 2024: Insilico Medicine to Present Preclinical Data for AI-Generated Cancer Drugs
Is any protein target truly undruggable?
Though most cancer targets have been considered conventionally “undruggable” (roughly 80 percent, according to Liron Bar-Peled, PhD, an investigator in Mass General’s Krantz Family Center for Cancer Research), that...
Digital Science announces new campaign to celebrate and understand ‘Research Transformation’
A new campaign entitled ‘Research Transformation’ is being launched by Digital Science to celebrate the art of change within the research sector.
Credit: Digital Science
A new campaign entitled ‘Research Transformation’ is being launched by Digital...
RedShiftBio Welcomes Sebastian Arevalo as New Sales Leader
RedShiftBio is thrilled to announce the appointment of Sebastian Arevalo as Vice President of Sales. With over two decades of experience in the biotechnology and life sciences sectors, Sebastian brings a wealth of expertise...
Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing...
Xcell Biosciences Boosts Cell and Gene Therapy Collaboration with Labcorp
Xcell Biosciences added new elements to its research collaboration agreement with Labcorp, which will now participate in the beta program for Xcellbio’s clinical manufacturing line of AVATAR instruments and has been given an observer...
StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates
At its annual Vaccines Day and Business Update on Wednesday, Moderna (MRNA) sought to show analysts and investors just how much its pipeline has advanced, four years after making history by harnessing mRNA technology...
Chemically bonded Mn₀․₅Cd₀․₅S/BiOBr S-scheme photocatalyst with rich oxygen vacancies for improved photocatalytic decontamination performance
A challenge in promoting the industrial application of photocatalysis technology for environment remediation lies in the design of high-performance photocatalysts. These photocatalysts should be endowed with efficient photo-carrier separation and intense redox potentials to...
Toxic water alert: study shows common water pollutants cause heart damage in fish could...
Recent findings highlight the persistence of Dihalogenated Nitrophenols (2,6-DHNPs) in drinking water, resisting standard treatments like sedimentation, filtration, and boiling. The research demonstrates the severe cardiotoxic effects of these contaminants on zebrafish embryos at...
New study to test novel psychedelic compound as potential treatment for alcohol use disorder
Modern mental health company Clerkenwell Health announced today that it is working with clinical-stage biotechnology company Beckley Psytech on a Phase IIa study investigating whether a novel psychedelic compound, combined with psychological support, could be an effective treatment...
